BCMTexas Children's HospitalJan and Dan Duncan Neurological Research Institute
Department of Neurology   |   Department of Molecular and Human Genetics
Welcome      |      Research      |      Our Team      |      Publications      |      For Patients      |      Contact Us
Publications

Papers    |    Recent Meeting Abstracts

Recent Meeting Abstracts

Shulman JM, Yu, L, Keenan BT, Buchman, A, Evans, DA, Schneider, JA, Bennett, DA, De Jager, PL. Exploring the Impact of Parkinsonís Disease Susceptibility Loci in Older Persons without PD. Platform presentation at the 65th annual meeting of the American Academy of Neurology (AAN), in San Diego, CA. (Mar. 16-23, 2013).

Shulman JM, Chen K, Keenan BT, Chibnik LB, Thiyyagura P, McCabe C, et al. Genetic susceptibility for amyloid pathology in Alzheimer's disease. Platform and poster presentations at the American Neurological Association (ANA), 137th Annual Meeting in Boston, MA. (Oct. 7-9, 2012).

Shulman JM, Imboywa S, Diamond AE, Chipendo P, De Jager PL, Feany MB. Integrating human and fly genetics to understand Alzheimer's disease susceptibility. Poster presentation at the American Neurological Association (ANA), 137th Annual Meeting in Boston, MA. (Oct. 7-9, 2012).

Shulman JM. Genetic analyses of Parkinson's disease endophenotypes. Platform presentation at the Parkinson Study Group (PSG), 26th Annual Symposium on Etiology, Pathogenesis, and Treatment of Parkinson Disease and Other Movement Disorders in Irving, Texas (May 11, 2012).

Keenan B, Shulman J, Chibnik L, Corneveaux J, Allen A, Myers A, et al. A candidate causal variant in the CR1 locus. Alzheimers Dement. 2011;7(4 Suppl):S496-S7. Poster presentation at the Alzheimer’s Association International Conference in Vancouver, Canada (July 15-18, 2012).

Raj T, Shulman J, Chibnik L, Keenan B, Stranger B, Evans D, et al. Alzheimer's disease susceptibility loci: Evidence for natural selection and altered gene expression. Alzheimers Dement. 2011;7(4 Suppl):S183. Poster presentation at the Alzheimer’s Association International Conference in Vancouver, Canada (July 15-18, 2012).

Sherva R, Tripodis Y, Shulman J, Chibnik L, Crane P, Bennett D, et al. Genetic factors associated with the rate of cognitive decline in Alzheimer's disease. Alzheimers Dement. 2011;7(4 Suppl):S496. Platform presentation at the Alzheimer’s Association International Conference in Paris, France (July 16-21, 2011).

Shulman J, Chibnik L, Keenan B, Destefano A, Leurgans S, Wilson R, et al. A genome-wide association scan for episodic memory decline in aging. Alzheimers Dement. 2011;7(4 Suppl):S195. Poster presentation at the Alzheimer’s Association International Conference in Paris, France (July 16-21, 2011).

Shulman J, Chipendo P, Chibnik L, Keenan B, Tran D, Aubin C, et al. Integrating genome-wide association and functional validation to understand susceptibility for Alzheimer's pathology. Alzheimers Dement. 2011;7(4 Suppl):S497. Platform presentation at the Alzheimer’s Association International Conference in Paris, France (July 16-21, 2011).

Shulman JM, Chibnik LB, Leurgans SE, Wilson RS, Tran D, Keenan BT, et al. A genome-wide association scan for episodic memory decline in aging. Neurology. 2011;76(Suppl 4):A1-2. Platform presentation at the American Academy of Neurology meeting in Honolulu, HI (April 9-16, 2011).

Shulman JM, Chipendo PI, Chibnik LB, Keenan BT, Tran D, Huentelman MA, et al. Integrating genome-wide association and functional validation to understand susceptibility for Alzeheimer's pathology. Ann Neurol. 2011;70 Suppl 15:S50-1. Platform presentation at the American Academy of Neurology meeting in Honolulu, HI (April 9-16, 2011).

Shulman JM, Keenan BT, Chibnik LB, Raj T, Tran D, Aubin C, et al. Functional fine mapping of the CR1 locus identifies a causal variant for Alzheimer's disease susceptibility. Neurology. 2011;76(Suppl 4):A642. Platform presentation at the American Academy of Neurology meeting in Honolulu, HI (April 9-16, 2011).

Shulman JM. Enhancing power for gene discovery in Alzheimer's disease: Intermediate phenotypes and functional validation in drosophila. Platform presentation at the Keystone Symposium on Neurodegenerative Diseases in Taos, N.M. (Feb. 21-26, 2011).

Copyright © 2013 The Laboratory for Integrative Functional Genomics. All Rights Reserved. Site designed by Academic Web Pages.